About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT05219903

National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders

Eosinophilic gastrointestinal disorders (EGIDs) are a heterogeneous group of emerging chronic inflammatory diseases that may affect different gastrointestinal (GI) tracts. Based on the anatomical site...

Lead sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Amelia Licari, MD

CONTACT

+390382502629 a.licari@smatteo.pv.it

Martina Votto, MD, PhD

CONTACT

+390382502629 martinavotto@gmail.com

Sponsors

Lead Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Collaborators

Italian Society of Pediatric Allergy & Immunology - Pediatric Centers

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- All EGIDs patients aged 0-18 years and followed at the centers involved in the study will be considered eligible. Informed consent must be obtained from each enrolled patient and signed by a parent/legal guardian and patient (when older than six years).

Exclusion Criteria

•\- This study will not include patients with:
•1. a diagnosis of EGIDs made more than five years before the study participation;
•2. a diagnosis of EoE not in line with current international guidelines;
•3. a secondary cause of intestinal eosinophilic inflammation (inflammatory bowel diseases, autoimmune diseases, vasculitis, graft versus host disease, malignancies).

Related studies

RECRUITINGPhase 3

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

NCT07112378 · Eosinophilic Esophagitis (EoE)

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

NCT06693531 · Eosinophilic Esophagitis (EoE)

Eosinophilic Gastrointestinal Disorders Registry

NCT05199532 · Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, and more

RECRUITINGPhase 3

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

NCT06596252 · Eosinophilic Esophagitis

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 25, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment300

Start dateJan 2022

Last updatedJul 25, 2024

Condition

Eosinophilic Gastrointestinal Disorders Eosinophilic Esophagitis Eosinophilic Gastritis or Gastroenteritis Eosinophilic Colitis

Locations shown

IRCCS Policlinico San Matteo

Pavia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2024Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions